Jeonjinbio Co., Ltd. (KOSDAQ: 110020)
South Korea
· Delayed Price · Currency is KRW
2,560.00
-30.00 (-1.16%)
Jan 22, 2025, 3:00 PM KST
Jeonjinbio Revenue
Jeonjinbio had revenue of 5.25B KRW in the quarter ending September 30, 2024, with 18.42% growth. This brings the company's revenue in the last twelve months to 19.96B, up 51.16% year-over-year. In the year 2023, Jeonjinbio had annual revenue of 15.68B with 101.18% growth.
Revenue (ttm)
19.96B
Revenue Growth
+51.16%
P/S Ratio
1.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.68B | 7.89B | 101.18% |
Dec 31, 2022 | 7.79B | 4.58B | 142.48% |
Dec 31, 2021 | 3.21B | -652.23M | -16.87% |
Dec 31, 2020 | 3.87B | -82.35M | -2.09% |
Dec 31, 2019 | 3.95B | 2.56B | 185.24% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |